Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MRK US Equity

Merck & Co., Inc.Health Care · Pharmaceutical Preparations · CIK 310158 · FY ends Dec 31
$152.55
+3.56 (+2.39%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-288-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-228-K 8.01Other eventssec.gov ↗
2026-04-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-12-048-K 8.01Other eventssec.gov ↗
2025-10-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-09-098-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-09

Every row is a filed document, checked against its EDGAR index.